Artwork

Content provided by HemaSphere Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by HemaSphere Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer

24:32
 
Share
 

Manage episode 368119746 series 3484302
Content provided by HemaSphere Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by HemaSphere Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

As the overall cancer death rate has declined over past decades and cancer survival has increased, unforeseen challenges are emerging. Thrombocytopenia, often associated with cancer disease or anticancer therapy, will be more present in thrombotic cancer patients, but evidence on how to treat these patients is lacking. Prof Anna Falanga discusses these Guidelines with host Dr Stephen Hibbs in this HemaSphere Podcast episode. You can find the referenced article, in full and open access, here on the HemaSphere website, or watch the video on our YouTube channel.

  continue reading

11 episodes

Artwork
iconShare
 
Manage episode 368119746 series 3484302
Content provided by HemaSphere Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by HemaSphere Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

As the overall cancer death rate has declined over past decades and cancer survival has increased, unforeseen challenges are emerging. Thrombocytopenia, often associated with cancer disease or anticancer therapy, will be more present in thrombotic cancer patients, but evidence on how to treat these patients is lacking. Prof Anna Falanga discusses these Guidelines with host Dr Stephen Hibbs in this HemaSphere Podcast episode. You can find the referenced article, in full and open access, here on the HemaSphere website, or watch the video on our YouTube channel.

  continue reading

11 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide